Eight studies demonstrated that ASS expression was significantly increased in several types of gastric cancer, such as gastric intestinal-type adenocarcinoma (GITA), diffuse gastric adenocarcinoma (DGA) and gastric mixed adenocarcinoma (GMA) (Table I) (21,22,24–26). The gene discussed is ASS1; the disease is diffuse gastric adenocarcinoma.